Clinical Trial Update: Study of Tumor-shrinking Decoction (TSD) to Treat Symptomatic Uterine Fibroids [Phase 3]

View source ↗

Summary

Phase 3 trial summary of Tumor-shrinking Decoction (TSD) for symptomatic uterine fibroids (leiomyoma) completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leiomyoma
• Uterine Fibroids

Drugs mentioned

• Tumor-shrinking Decoction (TSD)

Snippet

Sponsor: The University of Hong Kong | Conditions: Leiomyoma | Phase 3 | Status: COMPLETED